Zobrazeno 1 - 10
of 1 043
pro vyhledávání: '"U, Sigwart"'
Publikováno v:
Cardiovascular Medicine. 13:228-234
Publikováno v:
Cardiology. 116:168-173
We describe the 10-year outcome of the first-in-human series of 12 patients with hypertrophic cardiomyopathy treated with alcohol septal ablation. There was no 30-day mortality. Survival free of death, internal cardiac defibrillator discharge for tre
Autor:
David Senouf, Françoise Boehlen, Guido Reber, Pierre Fontana, P. De Moerloose, U. Sigwart, Youssef Daali, François Mach
Publikováno v:
European Journal of Clinical Investigation. 35:476-481
Background Clopidogrel and statins are frequently coadministered in patients with ischemic heart diseases. Recent reports suggested that clopidogrel's effectiveness in inhibiting adenosine diphosphate (ADP)-induced platelets aggregation is attenuated
Publikováno v:
American Heart Journal. 143:A1-A5
Background Angiographic contrast media cause platelet activation and decrease aggregability in vitro. We have previously shown in vitro a significant antiplatelet effect of contrast media at the concentrations obtained locally in the coronary artery
Autor:
R, Roberts, U, Sigwart
Publikováno v:
Circulation. 104:2113-2116
Autor:
U. Sigwart
Publikováno v:
European Heart Journal Supplements. 3:L38-L42
Until 1994 surgical myotomy-myectomy was the most effective symptomatic treatment for patients with symptoms of hypertrophic cardiomyopathy and dynamic left ventricular outflow tract obstruction refractory to pacing and drug treatment. Similar functi
Autor:
R.H Stables Ma, U Sigwart
Publikováno v:
ACC Current Journal Review. 7:27-30
Autor:
U. Sigwart
Publikováno v:
European Heart Journal. 18:1068-1072
The question mark in the title of this paper may look outdated and even artificial in view of the recent exponential increase in the use of stents. This almost frightening upswing occurred after a little less than one decade following their introduct
Publikováno v:
Journal of Interventional Cardiology. 3:103-108
A practical, simple and cheap technique using a guidewire loop for transvenous measurement of the size of a patent foramen ovate is presented. We applied this device in four patients without complication. To clear a suspected cause of paradoxical emb
Autor:
S, Fokstuen, J L, Blouin, R, Lyle, R, Lerch, M, Beghetti, F, Mach, J, Sztajzel, S E, Antonarakis, U, Sigwart
Publikováno v:
Revue medicale suisse. 1(21)
Recent advances in molecular genetics have resulted in the identification of pathogenic mutations in a number of genes which cause hypertrophic cardiomyopathy (HCM). In order to integrate this increasing genetic knowledge of HCM into the cardiology c